Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218042 · ClinicalTrials.gov registry record · NA
Study of Procedural Efficiency in EBUS With Dual Versus Single NEEDLEs: Evaluating the Value of a Second Needle in EBUS as it Pertains to Economic and Environmental Impact
A NA study of Mediastinal and Hilar Lymphadenopathy, sponsored by Christopher Kapp.
- Active
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 3
- Study locations
NCT07218042: Active NA study of Mediastinal and Hilar Lymphadenopathy, sponsored by Christopher Kapp.
NCT07218042 is a NA study of Mediastinal and Hilar Lymphadenopathy that is active but no longer recruiting, run by Christopher Kapp. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218042, a NA study of Mediastinal and Hilar Lymphadenopathy, is active but no longer recruiting, sponsored by Christopher Kapp.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 3
- Study locations
Study Summary
Currently, the EBUS bronchoscopy procedure uses either one or two needles to perform the biopsy of the lymph node based on physician preference. We want to determine the optimal number of needles to use for future EBUS bronchoscopy procedures like the one you are scheduled to have for your care and investigate the economic and environmental impact and time involved in using one versus two needles.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles.
Study Locations (3)
California
- University of California, Davis - Sacramento
Illinois
- Northwestern University - Chicago
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT07218042 still lists
NCT07218042 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Mediastinal and Hilar Lymphadenopathy appearing as the primary indexed condition, and to 1 intervention - of which We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles. is the first listed.
NCT07218042 reports a single indexed study location in California, Illinois, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07218042 about?
NCT07218042 is a clinical study titled "Study of Procedural Efficiency in EBUS With Dual Versus Single NEEDLEs: Evaluating the Value of a Second Needle in EBUS as it Pertains to Economic and Environmental Impact". Currently, the EBUS bronchoscopy procedure uses either one or two needles to perform the biopsy of the lymph node based on physician preference. We want to determine the optimal number of needles to use for future EBUS bronchoscopy procedures like the one you are scheduled to have for your care and ...
What is the current status of trial NCT07218042?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2024-02-02. Estimated completion is 2025-12-31.
What conditions does trial NCT07218042 study?
This clinical trial studies the following conditions: Mediastinal and Hilar Lymphadenopathy.
What interventions are being tested in trial NCT07218042?
The interventions under investigation include: We randomized patients to the two arms above; there was no specific intervention performed other than randomizing patients to one or two needles. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07218042?
This trial is sponsored by Christopher Kapp, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07218042 being conducted?
This trial has 3 study locations across California, Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07218042's enrollment target sits among peer trials
126 749th of 2000 higher than 1,248 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI